S
Seamless Therapeutics
Biotech & Life Sciences · Dresden, Germany · Founded 2022
Gene-editing technologies to create precise, disease-modifying therapeutic candidates MoreLess
Seamless Therapeutics is a pioneering startup in the field of gene editing, focused on unlocking the full potential of recombinases—specialized enzymes that can precisely modify DNA. The company operates in the biotechnology and life sciences market, aiming to develop innovative treatments for a wide range of serious diseases by reprogramming these enzymes to repair faulty genes.
The primary clients of Seamless Therapeutics include pharmaceutical companies, research institutions, and healthcare providers who are looking for advanced gene editing solutions to treat genetic disorders. By leveraging its proprietary technology platform, Seamless Therapeutics is building a pipeline of disease-modifying product candidates that can address various medical conditions, thereby expanding the therapeutic potential of gene editing.
Seamless Therapeutics follows a business-to-business (B2B) model. It generates revenue through partnerships, licensing agreements, and potentially through the commercialization of its proprietary gene editing therapies. The company has secured significant seed financing, amounting to $12.5 million, from leading life science investors to advance its transformative gene editing platform.
The management team, led by co-founders Anne Kristin Heninger, PhD, and Felix Lansing, PhD, along with VP of Business Development Arturo Urrios, PhD, MBA, brings a wealth of experience and a shared vision to revolutionize the gene editing landscape. The company also benefits from the guidance of an experienced board and advisors, including Prof. Frank Buchholz and Karl PhD.
Seamless Therapeutics fosters a dynamic and collaborative work environment, encouraging creativity, leadership, and teamwork. The company is always on the lookout for dedicated and visionary employees to join its mission of transforming gene editing.
Keywords: gene editing, recombinases, biotechnology, life sciences, disease-modifying, DNA repair, pharmaceutical partnerships, innovative treatments, proprietary technology, healthcare solutions.
Company overview
Seamless Therapeutics company information
The essential company record, classifications and operating signals in one place.
- Status
- Operational
- Founded
- 2022
- Headquarters
- Dresden, Germany
- Employees
- 34
- Open positions
- None listed
- Dealroom signal
- 62.2
Valuation & funding
Seamless Therapeutics funding history
Company financing events and reported valuations.
| Deal type | Date | Amount | Valuation | Investors | Source |
|---|---|---|---|---|---|
| SEED✓Equity / VC | Jan 2025 | — | — | Forbion Capital Partners | — |
| SEED✓Equity / VC | Apr 2024 | $13M | $52M | Wellington Partners · Forbion Capital Partners | ↗ |
| GRANT✓Other financing | Mar 2023 | $0 | — | GO-Bio | ↗ |
| SEED✓Equity / VC | Mar 2023 | $13M | $50M | Forbion Capital Partners · Wellington Partners | ↗ |
| SPINOUT✓Other financing | Apr 2022 | $0 | — | Dresden University of Technology | ↗ |
Financials
Workforce over time
Available workforce history. Financial fields without reported data are omitted.
| Year | Employees |
|---|---|
| 2026 | 31 |
| 2025 | 39 |
| 2024 | 29 |
| 2023 | 19 |
Growth signals
Seamless Therapeutics website traffic
Latest recorded traffic for Seamless Therapeutics is 1.6K monthly website visits, down 36% over the last three months. Seamless Therapeutics's team declined 12.8% over the past year.
Comparisons
Seamless Therapeutics compared with similar companies
Dealroom’s weighted taxonomy model identifies the closest operating peers. Company identity and context stay open; selected comparison metrics preview what is available in the platform.
Talent graph
Seamless Therapeutics's talent
Source: Dealroom Talent Intelligence.
Investors
4 investors on Seamless Therapeutics's cap table
Sourced from Dealroom's funding and investor records.
Global footprint
Where Seamless Therapeutics has talent and traffic
team presence
In the news
Latest news about Seamless Therapeutics
Recent press, funding announcements, and product moves mentioning Seamless Therapeutics — open to read from the original sources.
Market sentiment
What the market is saying about Seamless Therapeutics
An AI-synthesized read of the highest-engagement posts about Seamless Therapeutics on X over the past 7 days. We rank by likes & retweets, ignore corporate channels, and surface the themes that broke out from real people.
Reading the room on X — pulling top posts and synthesizing themes…
Source: X recent search ranked by engagement (likes + retweets) · Synthesis by Claude · Cached for 1 hour
See Seamless Therapeutics’s full profile on Dealroom
Request a free trial to see the complete deal history, financials, people graph and growth signals.
Takes under a minute. Already use Dealroom? Log in.